Introduction {#s01}
============

Myelin insulates nerve fibers and promotes rapid propagation of action potentials. In addition to its role in nerve conduction, myelin facilitates the long-term survival of axons ([@bib44]). Loss or disruption of this myelin-trophic support results in axonal degeneration, which is the major cause of permanent neurological disability in inherited and acquired diseases of myelin ([@bib62]). Experimental manipulations of myelin gene expression have established that individual myelin proteins play essential roles in providing axonal trophic support and that these trophic functions are independent of any role these proteins play in myelin formation. Null mutations of the myelin-associated glycoprotein (MAG; [@bib65]), proteolipid protein (PLP; [@bib23]), and 2′,3′-cyclic nucleotide 3′-phosphodiesterase (CNP; [@bib36]) cause axonal degeneration. MAG and CNP deletions have little, if any, effect on central nervous system (CNS) myelination, whereas the PLP-null CNS is hypomyelinated. Axonal pathologies that precede axonal degeneration include altered axonal transport and axonal ovoid formation in PLP- and CNP-null mice ([@bib23]; [@bib36]) and reduced neurofilament phosphorylation and smaller axonal diameters in MAG-null mice ([@bib65]). These pathologies are most prominent in paranodal regions of the myelin internode, where myelin--axonal communication is most likely to occur.

Hereditary spastic paraplegia (HSP) is a diverse group of genetic disorders with a common clinical feature of lower limb spasticity caused by degeneration of long CNS axons. Over 70 HSP gene loci have been identified, and 22 HSP-causing genes have been cloned ([@bib10]; [@bib45]). Whole exome sequencing and protein network analysis identified 18 additional gene candidates for HSP ([@bib45]). Proteins encoded by most of these HSP genes are enriched in axons, where they participate in mitochondrial function ([@bib16]), fast axonal transport ([@bib54]; [@bib18]), ER morphogenesis/function ([@bib51]; [@bib41]), purine metabolism ([@bib1]), and membrane trafficking ([@bib64]). Four HSP-associated genes (PLP, fatty acid 2-hydroxylase, connexin 47, and MAG) are enriched in myelinating oligodendrocytes ([@bib45]). PLP is the most abundant protein in CNS myelin. Deletions and point mutations of the PLP gene cause HSP2 ([@bib54]; [@bib58]; [@bib18]; [@bib30]). Mice null for PLP develop a late-onset (\>12 mo) axonal degeneration characterized by altered axonal transport and axonal ovoids that initially accumulate in juxtaparanodal axoplasm ([@bib23]). We generated a mutant mouse model (referred to as P~0~-CNS mice) in which PLP is replaced with P~0~ protein, the major structural protein of peripheral nervous system myelin. P~0~-CNS and PLP-null optic nerves display similar axonal pathology ([@bib23]; [@bib18]; [@bib66]). Compared with PLP-null mice, P~0~-CNS mice have shorter myelin internodes, more paranodal axoplasm, increased axonal pathology, increased neurological disability, and less than half the life span of PLP-null mice ([@bib66]). P~0~-CNS mice, therefore, develop an accelerated form of HSP2, where axonal structural pathology is prominent by 6 mo of age. Although experimentally induced P~0~-CNS mice display many of the pathological and clinical features of HSP, there is no naturally occurring mammalian counterpart. Because of the rapid progression of axonal pathology, P~0~-CNS mice provide a more convenient HSP animal model than the original PLP-null mice and were used in this study.

Although little is known about the mechanisms underlying myelin-induced axon ovoid formation, an imbalance between axonal energy supply and demand has been postulated to cause axonal degeneration in primary diseases of myelin ([@bib63]; [@bib12]). Because of their length, axons must depend on their local environment for energy substrates. Up to 98% of the axonal surface is covered by myelin. Therefore, the oligodendrocyte is a likely source of axonal ATP substrates. Recent studies support the concept that oligodendrocytes transfer ATP substrates to axons via monocarboxylate transporter 1 (MCT1), which is enriched in paranodal regions of the myelin internode ([@bib38]; [@bib42]; [@bib52], [@bib53]). In the present study, we find that mitochondrial dysfunction/degeneration and reduced axonal ATP production are prominent features of axonal pathology in P~0~-CNS mice. Because P~0~-CNS mice have clinical and pathological phenotypes similar to those caused by mutations in proteins enriched in or associated with axonal mitochondria and smooth ER (SER), our experiments suggest that reduced mitochondrial function in juxtaparanodal axoplasm may be a convergent mechanism of axonal degeneration in many forms of HSP and possibly other neurodegenerative diseases.

Results {#s02}
=======

Axonal mitochondria in P~0~-CNS axons {#s03}
-------------------------------------

We used serial blockface scanning 3D EM to reconstruct segments of 1-mo-old wild-type (WT; [Fig. 1, A--C](#fig1){ref-type="fig"}) and P~0~-CNS ([Fig. 1, D--F](#fig1){ref-type="fig"}) optic nerve axons at nanometer resolution. We reconstructed axonal mitochondria ([Fig. 1, C and F](#fig1){ref-type="fig"}; individual mitochondria are displayed as different colors) and compared their numbers and sizes in juxtaparanodal axoplasm (mitochondria within 15 µm of nodes) and internodal axoplasm (located \>15 µm from the node). Compared with WT axons, there was a significant increase (approximately twofold) in the number of juxtaparanodal mitochondria in P~0~-CNS axons ([Fig. 1 G](#fig1){ref-type="fig"}). The number of internodal mitochondria was similar in P~0~-CNS and WT axons ([Fig. 1 G](#fig1){ref-type="fig"}). Individual mitochondria in both juxtaparanodal and internodal P~0~-CNS axoplasm, however, were significantly shorter ([Fig. 1 H](#fig1){ref-type="fig"}) and slightly thicker ([Fig. 1 I](#fig1){ref-type="fig"}) when compared with WT mitochondria. Compared with WT axons, the volume of individual mitochondria in P~0~-CNS fibers was decreased by ∼50% in juxtaparanodal axoplasm ([Fig. 1 J](#fig1){ref-type="fig"}). Because of increased mitochondrial numbers, however, total mitochondrial volume was significantly increased in P~0~-CNS juxtaparanodal axoplasm when compared with mitochondrial volume in WT juxtaparanodal axoplasm ([Fig. 1 K](#fig1){ref-type="fig"}).

![**Mitochondria in 1-mo-old WT and P~0~-CNS optic nerve axons.** (A--F) 3D EM reconstructions of 1-mo-old WT (A--C) and P~0~-CNS (D--F) optic nerve segments showing 3D organization of fibers (A and D), a single-slice view of a myelinated axon (B and E), and 3D reconstructions of mitochondria in single axons (C and F; individual mitochondria are shown as different colors). Bars, 1 µm. m, mitochondria. (G) Mitochondrial numbers were increased in P~0~-CNS juxtaparanodal axoplasm and were similar in WT and P~0~-CNS internodal axoplasm. (H and I) Compared with mitochondria in WT axons, individual mitochondria in P~0~-CNS axons were significantly shorter (H) and slightly thicker (I). (J) The volumes of individual mitochondria were decreased in P~0~-CNS juxtaparanodal axoplasm and internodal axoplasm. (K) Total mitochondrial volumes were increased in P~0~-CNS juxtaparanodal axoplasm and were similar in WT and P~0~-CNS internodal cytoplasm. Jxpn, juxtaparanodal; Ax, axon; P, paranode; N, node. (G--K) Bar, median; box, 25--75%; whiskers show range; \*\*, P \< 0.01; \*\*\*, P \< 0.001; WT versus P~0~-CNS, Wilcoxon signed-rank test with Bonferroni's correction for multiple comparisons. Data were pooled for mitochondria (H--J, *n* = 44, 115, 210, and 198) and axons (G and K, *n* = 19, 22, 37, and 40) from three animals for analysis.](JCB_201607099_Fig1){#fig1}

Because axonal pathology is most prominent in distal juxtaparanodes of adult P~0~-CNS axons ([@bib66]), we compared mitochondrial numbers and axonal diameters in distal and proximal juxtaparanodal axoplasm in 1-mo-old WT ([Fig. 2 A](#fig2){ref-type="fig"}) and P~0~-CNS optic nerve fibers ([Fig. 2 B](#fig2){ref-type="fig"}). Mitochondrial numbers ([Fig. 2 C](#fig2){ref-type="fig"}) and axonal diameters ([Fig. 2 D](#fig2){ref-type="fig"}) were significantly increased in P~0~-CNS distal juxtaparanodal axoplasm when compared with WT distal juxtaparanodal axoplasm. Similar, but less dramatic, changes in mitochondrial numbers were present in proximal juxtaparanodal axoplasm ([Fig. 2 C](#fig2){ref-type="fig"}). The increase in distal juxtaparanodal axon diameter correlated with the positioning of mitochondria beneath the axolemma ([Fig. 2 B](#fig2){ref-type="fig"}). In 1-mo-old P~0~-CNS axons, mitochondria did not accumulate beneath Schmidt-Lanterman incisures (SLIs; Fig. S1, A and B), which form in P~0~-CNS internodes ([@bib67]), nor were they accompanied by accumulations of vesicles and dense bodies, which were present in 6-mo-old P~0~-CNS mice (Fig. S1 C). We next asked whether mitochondria in 1-mo-old P~0~-CNS axons displayed ultrastructural changes associated with dysfunction and/or degeneration and whether these changes were more prominent in juxtaparanodal axoplasm than in internodal axoplasm. Mitochondria were binned into four groups: elongated with normal cristae ([Fig. 2 E](#fig2){ref-type="fig"}), round with normal cristae ([Fig. 2 F](#fig2){ref-type="fig"}), round with reduced/abnormal cristae ([Fig. 2 G](#fig2){ref-type="fig"}), and round with few or no cristae ([Fig. 2 H](#fig2){ref-type="fig"}). There was little difference in the distributions of mitochondrial morphologies in the internodal and juxtaparanodal axoplasm of WT myelinated fibers or in the internodal axoplasm of P~0~-CNS myelinated fibers ([Fig. 2 I](#fig2){ref-type="fig"}). Elongated mitochondria comprised ∼70% of the mitochondria in both internodal (69%) and juxtaparanodal (73%) regions of WT axoplasm. 16% were round with normal cristae, and 11% were round with reduced or absent cristae. In 1-mo-old P~0~-CNS juxtaparanodal axoplasm, only 22% of mitochondria were elongated, 44% were round with normal cristae, and 34% were round with reduced or absent cristae ([Fig. 2 I](#fig2){ref-type="fig"}). These data establish that mitochondrial pathology is a prominent feature in juxtaparanodal axoplasm from 1-mo-old P~0~-CNS myelinated fibers. We also considered whether microtubule (MT) loss in juxtaparanodal axoplasm may have accounted for mitochondrial accumulation in 1-mo-old P~0~-CNS axons. WT juxtaparanodal/nodal axoplasm ([Fig. 2 J](#fig2){ref-type="fig"}) and the core of the P~0~-CNS juxtaparanodal/nodal axoplasm ([Fig. 2 K](#fig2){ref-type="fig"}) contained similar MT orientations ([Fig. 2, J and K](#fig2){ref-type="fig"}, green lines) and MT densities ([Fig. 2 L](#fig2){ref-type="fig"}). Thus, disassembly of MTs does not appear to be responsible for mitochondrial accumulation and displacement in 1-mo-old P~0~-CNS juxtaparanodal axoplasm.

![**Mitochondrial pathology and MT distribution in juxtaparanodal regions of 1-mo-old P~0~-CNS optic nerve axons.** (A) An electron micrograph shows a mitochondrion in WT juxtaparnodal axoplasm. (B) Mitochondria accumulated in P~0~-CNS juxtaparanodal axoplasm and were positioned beneath the axolemma. (C and D) Mitochondrial numbers (C) and axonal diameters (D) were similar in WT proximal and distal juxtaparanodal axoplasm (A). Compared with WT axons, mitochondrial numbers (C) were increased in P~0~-CNS juxtaparanodal axoplasm, and this resulted in increased axonal diameters (D). These increases were greater in distal compared with proximal juxtaparanodal axoplasm (B--D). (E--H) Mitochondrial morphology was binned into elongated with normal cristae (E), rounded with normal cristae (F), rounded with reduced cristae (G), and round with sparse or no cristae (H). (I) Most WT and internodal P~0~-CNS mitochondria were elongated, but most P~0~-CNS juxtaparanodal mitochondria were rounded with increased frequency of disrupted cristae. (J and K) MTs were traced in WT (J, green overlay) and P~0~-CNS juxtaparanodal axoplasm (K, green overlay). Bars, 0.5 µm. (L) MT density was similar in WT and the core of P~0~-CNS juxtaparanodal axoplasm. MTs were rarely detected in the swollen axoplasm that contained displaced mitochondria (B and K). m, mitochondria. (C, D, and L) Mean ± SEM of axonal values from three animals; \*, P \< 0.05; \*\*, P \< 0.02; *t* test.](JCB_201607099_Fig2){#fig2}

Mitochondrial outer membrane extensions and SER associations are altered in P~0~-CNS axons {#s04}
------------------------------------------------------------------------------------------

Mitochondria and SER interact morphologically and functionally ([@bib25]). To date, knowledge of the 3D distribution of SER in WT nerves is limited, and studies have not examined whether axonal SER or mitochondria--SER associations are altered in myelin diseases. To investigate the integrity of the SER network and its physical association with mitochondria, we traced SER and mitochondria in serial 3D EM images from 1-mo-old WT ([Fig. 3, A--C](#fig3){ref-type="fig"}) and P~0~-CNS ([Fig. 3, D--F](#fig3){ref-type="fig"}) myelinated optic nerve axons. Axonal SER cisternae formed a continuous and highly branched network of tubular structures (10--30 nm wide) in WT myelinated axons ([Fig. 3 B](#fig3){ref-type="fig"}). The overall distribution/density of SER was similar in WT ([Fig. 3 B](#fig3){ref-type="fig"}) and P~0~-CNS ([Fig. 3 E](#fig3){ref-type="fig"}) axons, with ∼3--4 µm of SER length per micrometer cubed of axoplasm ([Fig. 3 G](#fig3){ref-type="fig"}). The SER in P~0~-CNS axons, however, was often fragmented and was not as continuous as WT axonal SER ([Fig. 3 E](#fig3){ref-type="fig"}). Blunt ends of SER tubules were increased 2.3-fold in the juxtaparanodal axoplasm of P~0~-CNS fibers ([Fig. 3 H](#fig3){ref-type="fig"}).

![**Mitochondria--SER associations and mitochondrial outer membrane extensions in 1-mo-old WT and P~0~-CNS optic nerve axons.** (A--F) Images of 1-mo-old WT (A--C) and P~0~-CNS (D--F) optic nerves showing a single-slice view of myelinated axons by EM (A and D), 3D projections of SER (B and E), and individual mitochondria (C and F, multiple colors). m, mitochondria. (G and H) SER length relative to axonal volume was similar in WT and P~0~-CNS juxtaparanodal and internodal regions. (H) However, the number of SER termini per micrometer cubed of the axon was 2.5-fold greater in P~0~-CNS juxtaparanodal regions. (I and J) Extensions of the mitochondrial outer membranes occurred at the longitudinal ends of WT mitochondria (I, arrows). The SER closely apposed WT mitochondria and outer membrane extensions in single EM slices (I, arrowheads), and this association was fully delineated by 3D reconstruction of segmented SER (J, green) and mitochondria (J, red). (K and L) Mitochondria in P~0~-CNS juxtaparanodal axoplasm rarely extended outer membranes, and in 3D reconstructions (L), the surrounding SER was fragmented. (M) The percentage of mitochondria with outer membrane extensions was significantly reduced in P~0~-CNS juxtaparanodal and internodal axoplasm. (N) SER associations with mitochondria were reduced in P~0~-CNS juxtaparanodal axoplasm (P \< 0.002). When present, outer membrane extensions in P~0~-CNS juxtaparanodal axoplasm were significantly shorter than outer membrane extensions in WT mitochondria or in P~0~-CNS internodal mitochondria (includes mitochondria with lengths of zero). (O) Total SER associated with mitochondria was greater in WT than in P~0~-CNS axons. (P and Q) SER associated with the mitochondrial body (P) and outer membrane extensions (Q) was extensive in WT axoplasm but was reduced in P~0~-CNS juxtaparanodal mitochondria (P) and was rare on extensions (Q). (R) Optic nerve axons contained elongated mitochondria with outer membrane extensions that increased mitochondrial length by two thirds and provided an interface for SER interaction (a). SER--mitochondrial outer membrane extensions (a) had a higher surface area to volume ratio than the main mitochondrion (b). In P~0~-CNS, increased proportions of rounded mitochondria with shorter or absent extensions (c) and SER fragmentation (e) reduced SER associations. (G, H, and M) Mean ± SEM; *t* test; means of three animals (1,528 mitochondria). (N--Q) Box plots: bar, median; box, 25--75%; whiskers, 97.5--2.5%. Wilcoxon signed-rank test with Bonferroni's correction; mitochondria (*n* = 28, 42, 63, and 62) pooled from three animals. \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.005. Bars: (A--F) 1 µm; (I--L) 0.5 µm.](JCB_201607099_Fig3){#fig3}

We next compared the relationship between SER and mitochondria in WT ([Fig. 3, I and J](#fig3){ref-type="fig"}) and P~0~-CNS ([Fig. 3, K and L](#fig3){ref-type="fig"}) axons and measured the length of SER that apposed the mitochondrial outer membrane by \<50 nm ([Fig. 3, M--Q](#fig3){ref-type="fig"}). In addition to SER--outer membrane associations on the main body of the mitochondrion, 3D reconstructions identified lateral extensions of the mitochondrial outer membrane ([Fig. 3 I](#fig3){ref-type="fig"}, arrows). These extensions had a luminal diameter of ∼120 nm ([Fig. 3 I](#fig3){ref-type="fig"}), and mitochondrial inner membranes were rarely present. Approximately 70% of the mitochondria in 1-mo-old WT optic nerves had mitochondrial outer membrane extensions ([Fig. 3, I and J](#fig3){ref-type="fig"}), which increased total mitochondrial length by ∼66% (Fig. S2 A). The median mitochondrial length was ∼1.7 µm ([Fig. 1 H](#fig1){ref-type="fig"}), whereas the median length of mitochondrial outer membrane extensions was ∼1.2 µm ([Fig. 3 N](#fig3){ref-type="fig"}). Three quarters of elongated mitochondria had extensions, as did half of the round mitochondria with normal cristae (Table S1). Approximately 10% of round mitochondria with reduced or absent cristae had extensions. Compared with WT axons, there was a 47% reduction in the percentage of P~0~-CNS internodal mitochondria with outer membrane extensions ([Fig. 3 M](#fig3){ref-type="fig"}) and a 69% decrease in the number of juxtaparanodal mitochondria with extensions ([Fig. 3 M](#fig3){ref-type="fig"}). Mitochondrial outer membrane extensions were significantly shorter in P~0~-CNS juxtaparanodal axoplasm ([Fig. 3 N](#fig3){ref-type="fig"}).

In WT axons, the total SER on mitochondria was slightly greater for juxtaparanodal mitochondria (2.4-µm median length) than for internodal mitochondria (1.7-µm median length; [Fig. 3 O](#fig3){ref-type="fig"}). In WT juxtaparanodal axoplasm, 1.8 µm of SER (median length) was associated with the body of the mitochondria ([Fig. 3 P](#fig3){ref-type="fig"}), and 0.6 µm was associated with mitochondrial outer membrane extensions ([Fig. 3 Q](#fig3){ref-type="fig"}). Total SER associated with mitochondria was significantly reduced in both P~0~-CNS internodal (1.0-µm median value) and juxtaparanodal (0.5-µm median value) axoplasm ([Fig. 3 O](#fig3){ref-type="fig"}). In P~0~-CNS juxtaparanodal axoplasm, SER associated with mitochondria was reduced by 86% ([Fig. 3 O](#fig3){ref-type="fig"}). SER associated with the mitochondrial body (0.6 µm) was reduced by 66% ([Fig. 3 Q](#fig3){ref-type="fig"} and Fig. S2 B), and SER associated with mitochondrial outer membrane extensions were reduced by almost 100% ([Fig. 3 P](#fig3){ref-type="fig"} and Fig. S2, C and D). As shown schematically in [Fig. 3 R](#fig3){ref-type="fig"} (a), extensions on mitochondria provide an increased interface for mitochondrial outer membrane--SER associations. The smaller luminal diameter of the extensions may also provide a higher surface area to volume ratio for molecular exchange than on the mitochondrial body ([Fig. 3 R](#fig3){ref-type="fig"}, b). Reductions in mitochondrial length and outer membrane extension size in rounded mitochondria ([Fig. 3 R](#fig3){ref-type="fig"}, c and d) decrease mitochondria--SER associations in P~0~-CNS axons. Fragmentation of the SER ([Fig. 3 R](#fig3){ref-type="fig"}, e) further reduces mitochondria--SER associations and disrupts SER continuity.

Axonal function and ATP production {#s05}
----------------------------------

To investigate whether reduced ATP production is associated with mitochondrial degeneration and reduced mitochondria--SER associations in P~0~-CNS optic nerves, we compared 1-mo-old WT and P~0~-CNS nerves. The drop in ATP levels ([Fig. 4 B](#fig4){ref-type="fig"}, orange) was further validated in experiments where optic nerves were exposed to a metabolic challenge caused by oxygen-glucose deprivation (OGD; [Fig. 4 A](#fig4){ref-type="fig"}). Optic nerve function was monitored quantitatively as the area under the supramaximal compound action potential (CAP). The CAP area is proportional to the total number of excited axons and represents a convenient and reliable means of monitoring optic nerve axon function ([@bib14]; [@bib59]). When challenged with 30 min of OGD, P~0~-CNS optic nerves ([Fig. 4 A](#fig4){ref-type="fig"}, orange circles) show an accelerated loss of function ([Fig. 4, A and E](#fig4){ref-type="fig"}; 20 min for P~0~-CNS and 30 min for control, P = 0.008) compared with control nerves ([Fig. 4 A](#fig4){ref-type="fig"}, green circles). There was also a statistically significant reduction (P = 0.03) in the percentage of P~0~-CNS axons recovering from 30 min of OGD ([Fig. 4 A](#fig4){ref-type="fig"}, inset). The rapid loss of axon function and the reduction in nerve function recovery are most likely caused by decreased ATP production, as previously shown ([@bib6]; [@bib5]), and not by glutamate excitotoxicity because 30 min of OGD leads to minimal glutamate accumulation ([@bib60]).

![**Increased vulnerability to energy deprivation and altered mitochondrial transport in optic nerves from P~0~-CNS mice.** (A) Recordings of CAPs in 1-mo-old P~0~-CNS mice (orange circles, *n* = 4) showed a rapid loss of CAPs and reduced recovery after 30 min of OGD compared with age-matched controls (green circles, *n* = 6). The inset bar graph summarizes recovery at the end of 2 h after OGD exposure. \*, P = 0.026. (B) ATP levels were reduced in optic nerves from 1-mo-old P~0~-CNS mice compared with controls. ATP levels were corrected to protein and normalized to WT controls. \*, P = 0.015. (C--F) In organotypic slice cultures, mitochondrial transport was altered in myelinated P~0~-CNS axons. (C and D) Node locations were identified after time-lapse imaging by immunostaining for Caspr (green) and registered to axonal Mito-Dendra2 labeling (red). Live time-lapse images of mitochondria (C′ and D′) are converted to kymographs (C″ and D″), where cessation of mitochondrial transport is frequently observed in P~0~-CNS axons (P~0~; D″, arrowheads). Bars: (horizontal) 10 µm; (vertical on kymograph) 100 s. (E) The mean speed of motile mitochondria was significantly reduced in P~0~-CNS axons compared with WT axons over the entire axon segment studied (All) and within internodal (Inter) and nodal--paranodal axoplasm (N-PN). The mean mitochondrial speed in P~0~-CNS axons was significantly reduced in nodal--paranodal axoplasm compared with internodal axoplasm. Bars and lines are mean + SEM. *n* = 27, 28, 23, 27, 22, and 24. (F) Mitochondrial stopping events were quantified in proximal (Prox) and distal (Dis) regions of the nodes. Stopping events were more common in the proximal juxtaparanode in WT axons and in the distal juxtaparanodal axoplasm in P~0~-CNS axons. Bars with boxes and lines are median, interquartile range, and maximum/minimum. \*, P \< 0.05; \*\*\*, P \< 0.001; *t* test; *n* = 32 and 23 (F) axons from three WT and three P~0~-CNS explants.](JCB_201607099_Fig4){#fig4}

Mitochondrial transport in P~0~-CNS axons {#s06}
-----------------------------------------

The accumulation of organelles in axonal ovoids in PLP-null and P~0~-CNS axons has been associated with impaired axonal transport ([@bib23]; [@bib18]; [@bib66]). We compared axonal mitochondrial distribution and transport in myelinated organotypic slice cultures from WT and P~0~-CNS cerebella ([Fig. 4, C--F](#fig4){ref-type="fig"}) as described previously ([@bib46]). Time-lapse images of fluorescently tagged Mito-Dendra2--positive axonal mitochondria were recorded in myelinated Purkinje cell axons, and kymographs of stationary and motile mitochondria were generated ([Fig. 4, C](#fig4){ref-type="fig"}', C", D', and D"). After live imaging, cultures were fixed, and nodal regions of the imaged axons were delineated by immunostaining for Caspr and registered with live imaging of the same fiber ([Fig. 4, C and D](#fig4){ref-type="fig"}). Large stationary mitochondria did not translocate in either the anterograde or retrograde directions ([Fig. 4, C](#fig4){ref-type="fig"}" and D", vertical stripes). Compared with WT axons, the mean transport speed of small motile mitochondria in P~0~-CNS axons was reduced by 40% over the total length of the axon ([Fig. 4 E](#fig4){ref-type="fig"}, All), by 38% in internodal axoplasm ([Fig. 4 E](#fig4){ref-type="fig"}, Inter), and by 50% in nodal--juxtaparanodal axoplasm ([Fig. 4 E](#fig4){ref-type="fig"}, N-PN). Motile mitochondria preferentially stopped in the proximal juxtaparanodal region in WT axons ([Fig. 4 F](#fig4){ref-type="fig"}). In contrast, motile mitochondria preferentially slowed or stopped in the distal juxtaparanodal region in P~0~-CNS axons ([Fig. 4 F](#fig4){ref-type="fig"}). These results demonstrate that mitochondrial transport in myelinated P~0~-CNS axons is impaired and preferentially affected in distal juxtaparanodal regions.

MT organization and stability in P~0~-CNS optic nerve axons {#s07}
-----------------------------------------------------------

MTs are the substrate for fast axonal transport of mitochondria ([@bib29]). The EM data described in [Fig. 2](#fig2){ref-type="fig"} (J--L) support normal MT orientations and densities in 1-mo-old P~0~-CNS optic nerves. To investigate whether MT organization was affected in distal paranodal axoplasm of older P~0~-CNS axons, we examined 6-mo-old WT and P~0~-CNS axons with high-voltage EM tomography. MTs in WT nodal and paranodal axoplasm were parallel to each other and the longitudinal orientation of the axon ([Fig. 5 A](#fig5){ref-type="fig"}). In contrast, paranodal MTs in the P~0~-CNS optic nerve axon ([Fig. 5 B](#fig5){ref-type="fig"}) had significantly shorter lengths (620 nm vs. 1,856 nm in WT) and greater curvature, including some that turned 180°. Thus, MT lengths in P~0~-CNS optic nerve axons were reduced threefold compared with control nerves ([Fig. 5 C](#fig5){ref-type="fig"}). Reduced MT stability appears to play a role in paranodal axonal pathology in 6-mo-old P~0~-CNS optic nerves. MTs can exist as stable polymers of α/β-tubulins with long assembly/disassembly half-lives, or they can rapidly cycle between de- and repolymerization states. The insoluble/soluble acetylated α-tubulin ratio, which is considered to be an indication of MT stability ([@bib56]; [@bib4]), was similar (∼0.8) in 1- and 6-mo-old WT and 1-mo-old P~0~-CNS optic nerves. In contrast, this ratio was significantly decreased in 6-mo-old P~0~-CNS optic nerves ([Fig. 5 D](#fig5){ref-type="fig"}). These data indicate a decrease in MT stability in 6-mo-old P~0~-CNS optic nerve axons.

![**MT organization and stability are altered in mature P~0~-CNS optic nerve axons.** (A) Axonal MTs in 3D EM tomograms of 6-mo-old WT optic nerves are straight and oriented parallel to the longitudinal axis of the axon. (B) MTs in 6-mo-old P~0~-CNS optic nerves are disorganized. (C) MT lengths in P~0~-CNS optic nerve axons are decreased threefold compared with MT lengths in WT axons (P \< 0.00000001). *n* = 46 and 566 MTs (WT and P~0~-CNS). (D) The soluble/insoluble tubulin ratio, an indicator of MT stability, declines with age in P~0~-CNS mice. *n* = 3, 3, 6, and 6 preps (1 mo WT, 1 mo P~0~-CNS, 6 mo WT, and 6 mo P~0~-CNS). (E--G) Quantification and localization of phosphorylated tau epitopes in 6-mo-old WT and P~0~-CNS optic nerve samples. (E and F) The phospo-tau epitopes, Ser199--202, Ser396, and Ser404, were decreased two- to threefold in P~0~-CNS samples (pooled samples analyzed by Kinexus; see Materials and methods). (F) Single pooled samples are from 10 WT and 20 P~0~-CNS nerves. (G) Double immunofluorescent labeling for the axonal marker Tuj1 (tubulin-βIII; green) and either the phospho-tau epitope Ser396 (red) or Ser199/202 tau (red) localized these phospho-tau epitopes in axonal ovoids. (H--J) Quantification and localization of GSK3-β, GSK3-β phospho-Ser9, and CDK5 in 6-mo-old WT and P~0~-CNS optic nerves. (H and I) GSK3-β was increased and GSK3-β phospho-Ser9 was decreased in P~0~-CNS optic nerves. CDK5 levels were also increased in P~0~-CNS optic nerves. (C, D, and I) Bars and lines are mean + SEM. \*\*\*, P \< 0.001; *t* test. *n* = 3 and 3 preps (WT and P~0~-CNS). (J) Staining of 6-mo-old P~0~-CNS optic nerve sections with neurofilament (NF; green), Tuj1 (tubulin-βIII; green), GSK3-β (red), and CDK5 (red). Expression of GSK3-β (red) and CDK5 (red) was enriched in ovoids. GSK3-β phospho-Ser9 (red) was not detected in ovoids. (G and J) Bars, 5 µm.](JCB_201607099_Fig5){#fig5}

Tau phosphorylation is increased in P~0~-CNS axons {#s08}
--------------------------------------------------

Axonal MT stability is also mediated by the MT-binding protein Tau. Tau stimulates MT polymerization, promotes MT stabilization, and modulates binding of kinesin and dynein to MTs ([@bib24]). Tau--MT binding is inhibited by phosphorylation within and adjacent to multiple MT-binding domains ([@bib11]). We compared the levels of phosphorylation at four tau residues in optic nerve homogenates from 6-mo-old WT and P~0~-CNS mice ([Fig. 5 E](#fig5){ref-type="fig"}) and detected a two- to threefold increase in the phosphorylation of Ser396 and Ser199/Ser202 in P~0~-CNS samples ([Fig. 5 F](#fig5){ref-type="fig"}). Phospho-Ser396 tau flanks MT-binding repeats and modulates MT binding ([@bib11]; [@bib31]; [@bib55]). Whole optic nerve biochemical analysis may include other sources of tau, including oligodendrocytes ([@bib2], [@bib3]). We colocalized phospho-Ser396 and phospho-Ser202 with the axonal markers tubulin-βIII or neurofilament and confirmed that they were enriched in axonal swellings in P~0~-CNS optic nerves ([Fig. 5 G](#fig5){ref-type="fig"}). Thus, tau hyperphosphorylation may contribute to MT instability in paranodal axonal swellings.

Multiple kinases can phosphorylate tau ([@bib19]; [@bib55]), including the β subunit of glycogen synthase 3 (GSK3) and CDK5. In Western blots, the GSK3 isoform (GSK3-β) and phosphorylation of GSK3-β at Ser9 were similar in 1-mo-old WT and P~0~-CNS optic nerves. In contrast, levels of GSK3-β subunits were significantly increased in 6-mo-old P~0~-CNS optic nerves, whereas GSK3-β phospho-Ser9 levels were significantly reduced ([Fig. 5, H and I](#fig5){ref-type="fig"}). Because GSK3 phosphorylation inactivates GSK3 kinase activity, elevated levels of GSK3 and reduced GSK3 phosphorylation in P~0~-CNS optic nerves are consistent with increased GSK3 activity and tau phosphorylation. CDK5 was also increased in 6-mo-old P~0~-CNS optic nerves ([Fig. 5, H and I](#fig5){ref-type="fig"}). GSK3-β and CDK5 were enriched in axon ovoids in P~0~-CNS optic nerves ([Fig. 5 J](#fig5){ref-type="fig"}). GSK3-β and GSK3-β phospho-Ser9 staining were faint in normal-appearing axons and present in glial processes. GSK3-β phospho-Ser9 staining was found in glial processes but not in P~0~-CNS axonal ovoids ([Fig. 5 J](#fig5){ref-type="fig"}), which supports increased GSK3-β kinase activity.

Discussion {#s09}
==========

Our results implicate mitochondrial degeneration and decreased mitochondria--SER associations as primary causes of axonal degeneration in a rodent model of inherited myelin disease. Decreased ATP levels, reduced mitochondrial cristae, and decreased recovery from OGD associate decreased axonal energy metabolism with these mitochondrial pathologies. Reduced mitochondria--SER associations implicate altered Ca^2+^ homeostasis as an additional contributor to juxtaparanodal axonal pathology in 1-mo-old P~0~-CNS optic nerves. Collectively, our results support the concept that oligodendrocytes sustain axonal viability by providing ATP substrates to the paranodal axoplasm and that reduced energy production is the likely cause of axonal degeneration in P~0~-CNS mice. Although the molecular mechanism responsible for this metabolic coupling remains to be established, it is likely to involve multiple oligodendrocyte/myelin proteins, including those that cause HSP (PLP, MAG, connexin 47, and fatty acid 2-hydroxylase).

Loss of PLP function causes axonal degeneration in both mouse and human. We consider loss of PLP function as the underlying cause of axonal pathology in P~0~-CNS optic nerves. The accelerated rate of axonal degeneration in P~0~-CNS mice (compared with PLP-null mice) is the result of an increase in juxtaparanodal regions caused by shorter myelin internodes ([@bib66]). Mice with both PLP and P~0~ have normal life spans and no axonal pathology ([@bib66]), so it is unlikely that P~0~ expression in CNS myelin directly impacts axonal viability. Expression of P~0~ in the absence of PLP, however, does induce the formation of SLIs in optic nerve myelin internodes ([@bib67]). SLIs, which are small cytoplasmic channels that connect outer and inner margins of the myelin sheath, are prominent features of mammalian peripheral nervous system myelin but are normally absent from CNS myelin internodes. In adult P~0~-CNS optic nerve axons, axoplasm beneath SLIs can contain occasional accumulations of mitochondria ([@bib67]). Mitochondria did not accumulate in axoplasm beneath SLIs in 1-mo-old P~0~-CNS optic nerves (Fig. S1, A and B). Although SLIs may contribute to axonal pathology in adult P~0~-CNS optic nerves, they do not appear to impact mitochondrial viability in 1-mo-old P~0~-CNS mice. Because SLIs are not a feature of PLP-null optic nerves, they can contribute to, but are not essential for, CNS axonal pathology.

The pathological hallmark of P~0~-CNS myelinated axons is accumulation of axonal organelles at distal juxtaparanodes. Our data suggest that this late-onset axonopathy (6--9 mo) is a consequence of reduced ATP production and of mitochondrial degeneration that is apparent at 1 mo of age. MT pathology prominent at 6 mo (decreased length, decreased stability, altered orientation, and increased phosphorylated tau) was not present at 1 mo of age. Accumulation of small vesicles, which is a prominent feature of 6-mo-old P~0~-CNS juxtaparanodal axoplasm (Fig. S1 C), was not present in 1-mo-old P~0~-CNS juxtaparanodal axoplasm ([Figs. 1 E](#fig1){ref-type="fig"}, [2 B](#fig2){ref-type="fig"}, and [3, D, I, and K](#fig3){ref-type="fig"}). Vesicular fast axonal transport is fueled by the glycolytic enzyme GAPDH, which binds to and travels with axonal vesicles in a huntingtin-dependent fashion ([@bib68]). The dissociation of vesicular transport from mitochondrial respiration assures fast vesicular transport in axoplasm devoid of mitochondria. In contrast, nodal function depends on mitochondrial respiration and oligodendrocyte-derived ATP substrates. The juxtaparanodal enrichment of mitochondrial pathology and ovoid formation in HSP reflects the high-energy demand of saltatory conduction and the select vulnerability of juxtaparanodal mitochondria to mutations in myelin genes.

Stationary mitochondria were increased in 1-mo-old P~0~-CNS paranodal axoplasm ([Fig. 4](#fig4){ref-type="fig"}). Two events could provide a possible mechanism for stationary mitochondrial generation in juxtaparanodal axoplasm. First, juxtaparanodal axonal mitochondria could undergo fission and increase the mitochondrial number. Second, increased stopping of transported motile mitochondria at distal juxtaparanodes (as demonstrated by our time-lapse imaging experiments; [Fig. 4](#fig4){ref-type="fig"}) and their fusion with mitochondria could increase mitochondrial volume. As previously demonstrated for demyelinated axons ([@bib34]; [@bib46], [@bib47]), P~0~-CNS axons may increase mitochondrial volume in juxtaparanodal axoplasm as a response to increased energy demands caused by mitochondrial degeneration and reduced ATP production. Degenerating mitochondria are displaced to peripheral juxtaparanodal axoplasm and increase axonal diameter ([Fig. 2](#fig2){ref-type="fig"}). When neurofilaments accumulate in axons as the result of ββ′-iminodipropionitrile toxicity, they are also displaced to the peripheral axoplasm ([@bib22]). Peripheral displacement of altered axonal organelles appears to be a mechanism used by axons to maintain a central core of normal axoplasm.

Recent studies support the concept that MCT1, which is enriched in myelin paranodes, releases lactate that is internalized into paranodal axoplasm and used by mitochondria for oxidative metabolism and ATP biosynthesis ([@bib21]; [@bib38]; [@bib42], [@bib43]; [@bib52]; [@bib28]). Attenuation of MCT1 levels in vivo and in vitro results in axonal degeneration ([@bib38]). Pharmacological inhibition of MCT1 in organotypic slice cultures also causes axonal degeneration, which can be rescued by adding free lactate to the culture medium ([@bib38]). Because lactate transfer cannot be directly measured, sorting primary and secondary effects of lactate deficiency in the environment of mitochondrial degeneration will require manipulation of MCT1 function in oligodendrocytes.

Mitochondrial dysfunction and increased intraaxonal Ca^2+^ are considered to be convergent mechanisms of axonal degeneration in chronic neurodegenerative diseases ([@bib13]). The ability to reconstruct mitochondria and SER in WT and P~0~-CNS axons at nanometer resolution allowed us to identify and expand previously described extensions of the mitochondrial outer membrane ([@bib57]). Approximately 70% of WT optic nerve axonal mitochondria had extensions of their outer membrane, which increased mitochondrial length and mitochondria--SER associations by 66%. Sites of close opposition between mitochondria and SER are referred to as the mitochondria-associated ER membrane (MAM; [@bib25]). Although the molecular composition of the MAM is not fully characterized, the SER MAM contains several Ca^2+^-binding chaperones ([@bib25]). It is possible that mitochondrial outer membrane extensions have a unique molecular signature that reflects specialized or enhanced MAM functions. In support of a specialized function, not all CNS axons have mitochondrial outer membrane extensions. Originally described in CNS axons ([@bib57]), they are abundant in optic nerves and rare in the corpus callosum and cerebellar axons ([@bib46], [@bib47]). They are not common in rodent liver ([@bib47]) but are a prominent feature of mitochondria in Sertoli cells ([@bib50]). Mitochondria in 1-mo-old P~0~-CNS paranodal axoplasm rarely extended their outer membranes, and the SER was fragmented. The 86% reduction in mitochondria--SER associations in P~0~-CNS axons may alter Ca^2+^ buffering and play a pivotal role in juxtaparanodal axonal dysfunction.

Paranodal axonal swellings are a pathological hallmark of HSPs caused by protein mutations that are enriched in myelin and axonal organelles (mitochondria, MTs, and SER; [@bib10]). Axon ovoids are also a common feature in peripheral nerves from individuals with Charcot-Marie-Tooth disease. Charcot-Marie-Tooth is caused by mutations in neuronal or Schwann cell genes and is considered to be the peripheral nerve equivalent of HSP ([@bib61]). Correlations between mutated genes and protein network analysis have also identified significant overlap between HSP genes and genes implicated in amyotrophic lateral sclerosis, Alzheimer's disease, and Parkinson's disease ([@bib45]). The major objective of this study was to elucidate the mechanism responsible for axonal degeneration in P~0~-CNS mice. Mitochondrial degeneration, reduced mitochondria--SER associations, and reduced ATP production are prominent features of axonal degeneration in P~0~-CNS axons and may drive aspects of axonal degeneration in a variety of CNS diseases.

Materials and methods {#s10}
=====================

Animals {#s11}
-------

We generated transgenic mice that expressed mouse P~0~ cDNA ([@bib39]) ligated to a 9.1-kb region of the mouse myelin basic protein promoter. This line has equal amounts of P~0~ and PLP in CNS myelin (PLP/P~0~-CNS mice; [@bib66]). By crossing PLP-null mice with PLP/P~0~-CNS mice, we obtained mice that were null for PLP and homozygous for the P~0~ transgene (P~0~-CNS). These mice have been described in detail previously ([@bib66]) and consist of B6129F1 (PLP null), FVB (PLP/P~0~-CNS mice), and B6129F1/FVB (P~0~-CNS) backgrounds. Because the PLP gene is X linked, our experiments only included male P~0~-CNS mice. WT male mice were used as controls and were of the same genetic background as P~0~-CNS mice.

3D EM reconstruction using serial blockface scanning EM {#s12}
-------------------------------------------------------

Tissue preparation and imaging were performed as previously described ([@bib46]) using en block staining methods ([@bib15]). In brief, P~0~-CNS and WT mice at 1 and 6 mo of age were perfused with 0.1-M sodium cacodylate buffer containing 2.5% glutaraldehyde (Electron Microscopy Sciences) and 4% paraformaldehyde. Optic nerves were dissected, cut into 5-mm segments, postfixed in 0.1% tannic acid in buffer, washed, and then stained successively with osmium ferricyanide, tetracarbohydrazide, aqueous osmium tetroxide, saturated aqueous uranyl acetate, and Walton's lead aspartate stains, as described previously ([@bib15]). Tissues were then dehydrated in graded ethanols and embedded in Procure 812 embedding resin at 60°C for 48 h.

Nerve segments were mounted on aluminum pins, trimmed, surrounded with silver paste, and examined in a Sigma VP scanning electron microscope (ZEISS) fitted with a 3View in-chamber ultramicrotome (Gatan) and a low-kilovolt backscattered electron detector (Gatan). Longitudinally oriented axons were imaged covering areas ∼80 µm wide and 80--400 µm in length. Images were collected at 1.8--2.5 kV, depending on tissue contrast, and up to 500 slices were cut at a thickness of 40--100 nm. Imaging was conducted using a 30-µm aperture in high-current mode and imaged at room temperature (21°C at a chamber vacuum of 10^−6^ mbar and working distance of 5.7 mm).

Images were reconstructed and registered using ImageJ/FIJI software (National Institutes of Health). Axons, SER, and mitochondria were segmented in each slice by a combination of signal intensity--based thresholding and manual segmentation using ImageJ with FIJI plugins or Reconstruct software (SynapseWeb; [@bib20]) and rendered using Blender software or Amira (v. 5.5.0; FEI Visualization Sciences Group), as described previously ([@bib46]). Volumes were calculated as the sum of areas in each slice multiplied by the slice thickness. Lengths were measured as 3D distances using polyline tools. Axonal and mitochondrial mean diameters were calculated using length and volume and assuming a cylindrical geometry. SER associated with the mitochondrial surface was measured as the length of SER within 50 nm of the mitochondrial surface. SER termini (SER fragmentation) were counted manually on projection images of a 5-µm-long segment of axon and expressed as termini per SER volume. Reconstructed single-slice views were assembled from multiple regions of interest obtained along a user-defined path through the stack (x, y, and z coordinates), e.g., along an axon centerline.

MT stability assay and Western blots {#s13}
------------------------------------

WT and P~0~-CNS optic nerves from 1- and 6-mo-old mice were homogenized and lysed in an MT stabilization buffer containing 100 mM Pipes, pH 6.9, 5 mM MgCl~2~, 1 mM EGTA, 30% glycerol, 0.1% Nonidet P-40, 0.1% Triton X-100, 0.1% Tween 20, 0.1% β-mercaptoethanol, 0.001% antifoam, 1 mM dithiothrietol, 1 mM GTP, 10 mM ATP, 10 µM Taxol, and 10 µl protease inhibitor cocktail (Cytoskeleton, Inc.). After centrifugation at 100,000 *g* for 30 min, supernatants containing soluble tubulin were separated from pellets containing polymerized tubulin. The pellets were dissolved in double-distilled deionized water for Western blotting with acetylated α-tubulin antibodies (mouse monoclonal; Sigma-Aldrich). Data are expressed as the insoluble/soluble acetylated α-tubulin ratio.

Phospho-site--specific kinase screening was performed by Kinexus Bioinformatics Corp. using antibody microarrays. Pooled samples from 20 (1 mo old) and 10 (6 mo old) optic nerves from WT and P~0~-CNS mice were collected and submitted to Kinexus for antibody microarray (KAM-1.3) testing using 500 Pan-Ab and 300 Phospho-Ab, which included phosphorylation states of tau and kinases. Analysis was undertaken using the KPSS 9.1 program by Kinexus.

Western blotting was performed on WT and P~0~-CNS optic nerves homogenized in 10 volumes of Tris-buffered saline containing 1 mM EDTA, 1 mM PMSF, and protease and phosphatase inhibitors (Sigma-Aldrich). Protein concentrations were determined by protein assays (Bio-Rad Laboratories). Proteins were separated on 4--12% NuPAGE MES gels (Thermo Fisher Scientific) and then transferred onto polyvinylidene fluoride membranes. Primary antibodies for Western blots included GSK3-αβ (mouse monoclonal; Enzo Life Sciences), 3β-pSer9 (rabbit polyclonal; Cell Signaling Technology), and Cdk5 (mouse monoclonal; EMD Millipore), with GAPDH as a loading control.

Immunocytochemistry {#s14}
-------------------

6-mo-old WT and P~0~-CNS mice were perfused with 4% paraformaldehyde. Optic nerves were removed, fixed overnight, and then cut at a thickness of 10 µm in a cryostat (Leica Biosystems). Sections were double immunostained for axons with Neurofilament-H (rabbit polyclonal; AbD Serotec) or tubulin-βIII (TUJ1; mouse monoclonal; Covance) and GSK3-αβ (mouse monoclonal), GSK3β-pSer9 (rabbit polyclonal), tau--phospho Ser396, tau--phospho Ser202 (rabbit polyclonal; Abcam), or Cdk5 (mouse monoclonal). Secondary antibodies were Alexa Fluor 488 or Alexa Fluor 594 conjugated (Invitrogen). Confocal images were collected using an SP5 confocal microscope (Leica Biosystems) using a 63× 1.4 NA oil immersion lens and acquiring images at room temperature using 488-nm and 561-nm laser lines and 1,024 × 1,024 pixel formats. Step sizes of 0.5 µm were used for z series acquisition. Images were reconstructed using ImageJ/FIJI software.

High-voltage transmission electron microscope tomography {#s15}
--------------------------------------------------------

WT and P~0~-CNS mice were perfused with 4% paraformaldehyde and 2.5% glutaraldehyde. Semi-thin serial sections (0.5 µm) of optic nerves were cut, placed on formvar-coated slotted grids, and stained with 1% uranyl acetate and 1% lead citrate. 3D reconstructions of axonal contents were collected as previously described ([@bib49]). In brief, for each reconstruction, a series of images at regular tilt increments was collected with a 4000EX intermediate-voltage electron microscope (JEOL USA) operated at 400 kV. Tilt series were recorded on film at ×20K at 2° angles from −60° to 60°. Negatives were digitized to produce images with 1.41 nm/pixel. The IMOD package ([@bib35]) was used for rough alignment, with fine alignment and reconstruction performed using the TxBR package ([@bib37]). Volume segmentation was performed by manual tracing using Xvoxtrace ([@bib48]), and reconstructions were visualized using Analyze (Mayo Foundation), Synu ([@bib26]), and Amira (Mercury/TGS) software.

Preparation of optic nerves, recording techniques, and OGD {#s16}
----------------------------------------------------------

These procedures were performed as previously described ([@bib7], [@bib8], [@bib9]). In brief, mouse optic nerves were obtained from 1-mo-old P~0~-CNS and WT mice and placed in a perfusion chamber superfused with artificial cerebrospinal fluid (ACSF) and continuously aerated by a humidified gas mixture of 95% O~2~/5% CO~2~. All experiments were performed at 37°C. Suction electrodes back-filled with ACSF were used for stimulation (Isostim 520; WPI) and for recording the CAP. The recording electrode was connected to an amplifier (Axoclamp 900A; Molecular Devices), and the signal was amplified 50 times, filtered at 30 kHz, and acquired at 20--30 kHz. Axon pClamp 10 software (Molecular Devices) was used for data acquisition. Stimulus pulse (50-µs duration) strength was adjusted to evoke the maximum CAP and then increased another 25% for supramaximal stimulation. The supramaximal CAP was elicited every 30 s. OGD stress was induced by switching to glucose-free ACSF (replaced with equimolar sucrose to maintain osmolarity) and a gas mixture containing 95% N~2~/5% CO~2~. OGD was applied for 30 min, ACSF and O~2~ were restored, and CAPs were recorded for up to 5 h after the end of OGD. Optic nerve function was monitored quantitatively as the area under the supramaximal CAP. Original data were normalized by setting the mean of initial baseline values (measured over 15 min) to a value of 1.0. Results from several nerves were pooled, averaged, and plotted against time. All data are presented as the mean ± SEM. Statistical significance was determined by unpaired two-tailed Student's *t* tests or analyses of variance (ANOVAs). ANOVAs were followed by Bonferroni's post-hoc test (Prism 4; GraphPad Software). The *n* values indicate the number of optic nerves.

ATP measurements {#s17}
----------------

ATP extraction was performed as previously described ([@bib33]) and modified for optic nerve as described in previous publications ([@bib7], [@bib8]). In brief, nerves were diced and placed in 75 µl of 10% perchloric acid (HClO~4~), sonicated, and centrifuged at 4,500 rpm for 10 min at 4°C. The supernatant was neutralized with 30 µl of 2.5 M potassium hydroxide (KOH) and centrifuged at 14,000 rpm for 10 min at 4°C. Total cellular ATP was measured using a bioluminescence assay kit (11 699 709 001; Roche). The absorbance was measured at 560 nm. The blank values were subtracted from the raw data, and ATP concentrations were calculated from a log--log plot of the standard curve and were normalized to protein concentration. The values are expressed as micromoles of ATP per milligram of protein. Protein content was quantified in one nerve, and ATP levels were measured in the other.

Myelinating organotypic cerebellar slice cultures {#s18}
-------------------------------------------------

Tissue preparation and imaging were performed as previously described ([@bib46]). Myelinating organotypic cultures were generated from 150--200-µm-thick slices of P8-10 cerebellum from WT and P~0~-CNS mice ([@bib17]). The slices were cultured on Millicell organotypic culture inserts (EMD Millipore) in 6-well plates containing 50% minimal essential medium, 25% horse serum, 25% HBSS, 6 mg/ml [d]{.smallcaps}-glucose, 1× Glutamax (Invitrogen), and penicillin/streptomycin. 2 h after plating, the lentiviral vectors were injected into the Purkinje cell layer using a glass microinjection needle ([@bib32]).

Lentivirus with mitochondria-targeted Dendra2 was prepared using a pLenti6/V5 directional TOPO cloning kit (Invitrogen) according to the manufacturer's protocol with slight modifications ([@bib27]). In brief, 293FT cells were transfected with pLentiV5/6 lentiviral vector including Mito-Dendra2 (Takara Bio Inc.) and packaging plasmids. The medium was changed 4 h after the transfection. Viral supernatants were collected 24 h after the transfection, filtered with 0.22 µm polyvinylidene fluoride membrane (EMD Millipore), and centrifuged at 100,000 *g* for 2 h. The viral pellet was suspended in a 1/100 volume of PBS.

Purkinje cell axons with Dendra2-positive mitochondria were imaged by confocal microscopy as reported previously ([@bib46]). Glass-bottom dishes with culture medium and pieces of Millicell membrane with attached slices were transferred into a microincubator (PDMI-2; Medical System) attached to an inverted laser-scanning confocal microscope (TCS SP; Leica Biosystems). The slices were illuminated with 488-nm light through a 40× oil immersion objective (NA 1.21; Leica Biosystems). Images of mitochondria were collected at 1,024 × 1,024 pixel resolution every 6 s. Imaging at 6-s intervals did not induce mitochondrial fragmentation, acute mitochondrial swelling, or cessation of axonal transport.

Kymographs of mitochondria in time-lapse images were produced using ImageJ as described previously ([@bib40]). Motile mitochondria were identified as moving diagonal lines in kymographs. Mean velocity of motile mitochondria was measured by dividing total displacement distance by total time in juxtaparanodal (\<15 µm from nodes) and internodal (15--40 µm from nodes) axoplasm. After time-lapse imaging, slices were fixed with buffered 4% paraformaldehyde for 6 h and immunostained for Caspr to establish the location of the paranodal/nodal axoplasm ([@bib46]). The immunostained images were coregistered with kymographs, and stopping events were quantified in proximal and distal juxtaparanodal regions (∼2.5--17.5 µm from the center of nodes).

Statistical analysis {#s19}
--------------------

Mitochondrial size, shape, and volume data were tested for normal distributions using the Kolmogorov-Smirnoff test (α = 0.05). Where normally distributed, groups were compared using ANOVAs and two-tailed Student's *t* tests with Bonferroni's correction for multiple comparisons where appropriate. Kruskal-Wallis comparisons and Wilcoxon signed-rank tests (two-tailed with Bonferroni corrections to α levels for multiple comparisons) were used for nonparametric data. Mitochondrial pathology categorical data were compared between groups using Fisher's exact test. Statistical testing was performed using R or SigmaStat software.

Online supplemental material {#s20}
----------------------------

Fig. S1 shows electron micrographs of optic nerve axons from 1- and 6-mo-old P~0~-CNS mice. Fig. S2 shows how mitochondrial outer membrane extensions increase mitochondria--SER associations in optic nerve axons from 1-mo-old mice. Table S1 shows the percentage of mitochondria with normal and pathological morphologies ([Fig. 2, E--I](#fig2){ref-type="fig"}) bearing outer membrane extensions.
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